Sen. Ron Johnson: 5 Questions for FDA About Pfizer Vaccine Approval
Senator Ron Johnson (R-Wis.) on Thursday sent a letter to Dr. Janet Woodruff, acting commissioner of the U.S. Food and Drug Administration, demanding answers to five questions pertaining to the FDA’s approval of the Pfizer Comirnaty COVID vaccine.
Sen. Ron Johnson (R-Wis.) on Thursday sent a letter to Dr. Janet Woodruff, acting commissioner of the U.S. Food and Drug Administration (FDA), demanding answers to five questions pertaining to the FDA’s approval of the Pfizer Comirnaty COVID vaccine.
The FDA on Aug. 23 granted full approval to Pfizer’s vaccine, over the objections of some scientists who pointed out that full approval was based on only six months’ worth of data — despite clinical trials designed for two years — and that there was no public discussion of the data.
In his Aug. 26 letter, Johnson asked questions similar to those raised earlier this week by Children’s Health Defense Chairman Robert F. Kennedy, Jr. and Dr. Meryl Nass about the legal distinction between the Pfizer-BioNTech vaccine being administered under Emergency Use Authorization, and Pfizer’s Comirnaty vaccine, which was granted full licensure.
In his letter, Johnson asks these five questions:
1. Why didn’t the FDA grant full licensure for the Pfizer-BioNTech vaccine that is in use and available in the U.S.?
2. How are the Comirnaty and Pfizer-BioNTech COVID-19 vaccines “legally distinct” and what are the “certain differences”?
3. There is no doubt that the FDA’s action will lead to more vaccine mandates and increased pressure on those currently choosing not to get vaccinated. Your letter to Pfizer suggests that “there is not sufficient approved vaccine available for distribution.” Is there sufficient supply in the U.S. of the Comirnaty vaccine to ensure that those being vaccinated under mandates will be receiving the FDA-approved version? Or is it more likely (or certain) that they will be vaccinated using the vaccine administered under the reissued EUA?
4. If there is insufficient supply of Comirnaty vaccines for those succumbing to the coercion of mandates, isn’t the FDA de facto endorsing vaccine mandates utilizing EUA vaccines?
5. Will individuals who receive either vaccine be afforded the same legal protections if they are injured by the vaccine? If not, why not?
This isn’t the first time Johnson has written the FDA about COVID vaccines. On Aug. 22, he sent a letter to Woodcock; Dr. Francis Collins, director of the National Institutes of Health (NIH); and Dr. Rochelle P. Walensky, director of Centers for Disease Control and Prevention, criticizing the FDA’s decision not to hold a formal advisory committee meeting to discuss Pfizer’s application for full approval of its vaccine.
In July, Johnson held a news conference with families injured by the vaccines, during which he said the medical community was “repeatedly ignoring” the vaccine-injured.
The above article (Sen. Ron Johnson: 5 Questions for FDA About Pfizer Vaccine Approval) was originally published on The Defender and is re-published here by ‘contribution’ with attribution to the author, Children’s Health Defense Team and The Defender.
Read more articles by: Children’s Health Defense Team
TLB Editors Note: TLB highly recommends you click on the image (the Defender) below, visit this great website, and do whatever you can to help see this vital forum succeed … for the sake of our children !!!
Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. CHD is planning many strategies, including legal, in an effort to defend the health of our children and obtain justice for those already injured. Your support is essential to CHD’s successful mission.
Click on image below to visit site:
Stay tuned to …
The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)
Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.
Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.